NCT06740188View on ClinicalTrials.gov

Trazodone on NREM Sleep Stage Ⅲ in Depressed Insomniac Co-morbid Patients

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Depressed Insomniac Co-morbid Patients
Interventions
DRUG

5-hydroxytryptamine balanced antidepressants trazodone

The intervention group was given only 5-hydroxytryptamine balanced antidepressants trazodone

DRUG

Citalopram hydrobromide combined with zolpidem

the control group was given citalopram hydrobromide combined with zolpidem

Trial Locations (1)

200124

RECRUITING

Tongji University, Shanghai

All Listed Sponsors
lead

Tongji University

OTHER

NCT06740188 - Trazodone on NREM Sleep Stage Ⅲ in Depressed Insomniac Co-morbid Patients | Biotech Hunter | Biotech Hunter